New Mountain Vantage Advisers’s Thermo Fisher Scientific TMO Stock Holding History

New Mountain Vantage Advisers’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-173,228	Closed	-$24.6M	–	40
2015 Q4	$24.6M	Sell	173,228 -140,759	-45%	-$18.8M	1.14%	32
2015 Q3	$38.4M	Sell	313,987 -120,497	-28%	-$15.7M	1.49%	29
2015 Q2	$56.4M	Sell	434,484 -11,590	-3%	-$1.51M	2.31%	20
2015 Q1	$59.9M	Sell	446,074 -44,002	-9%	-$5.67M	2.66%	14
2014 Q4	$61.4M	Buy	490,076 +4,822	+1%	+$586K	2.66%	15
2014 Q3	$59.1M	Buy	485,254 +61,507	+15%	+$7.48M	2.57%	14
2014 Q2	$50M	Buy	423,747 +59,786	+16%	+$7.04M	2.18%	21
2014 Q1	$43.8M	Sell	363,961 -364,455	-50%	-$43.3M	2.25%	20
2013 Q4	$81.1M	Sell	728,416 -19,703	-3%	-$1.96M	4.02%	7
2013 Q3	$68.9M	Buy	748,119 +44,923	+6%	+$4.06M	4.22%	8
2013 Q2	$59.5M	Buy	+703,196	New	+$58.5M	3.58%	10

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

New Mountain Vantage Advisers's TMO Position: Q1 2016 in Review

New Mountain Vantage Advisers sold out of Thermo Fisher Scientific (TMO) in Q1 2016, closing a stake of 173,228 shares — an estimated $24.6M sold.

New Mountain Vantage Advisers first reported a position in TMO in Q2 2013 and held it in 11 quarters. The position peaked at $81.1M in Q4 2013. 1,024 funds tracked by Wall St. Rank hold TMO as of Q1 2016.

New Mountain Vantage Advisers reported no remaining Thermo Fisher Scientific position as of Q1 2016 after selling out during the quarter.
New Mountain Vantage Advisers sold 173,228 Thermo Fisher Scientific shares in Q1 2016, an estimated $24.6M.
New Mountain Vantage Advisers first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 11 quarters.
New Mountain Vantage Advisers's Thermo Fisher Scientific position peaked at $81.1M in Q4 2013.
1,024 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2016.

Based on New Mountain Vantage Advisers's 13F filing for Q1 2016, filed 16 May 2016.